Filing Details
- Accession Number:
- 0000911916-18-000026
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-02-14 09:35:31
- Reporting Period:
- 2018-02-12
- Accepted Time:
- 2018-02-14 09:35:31
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1136869 | Zimmer Biomet Holdings Inc. | ZBH | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 134151777 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1346672 | F Chad Phipps | C/O Zimmer, Inc. P. O. Box 708 Warsaw IN 46580 | Sr. Vp/Gen Counsel/Secretary | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-02-12 | 27,000 | $78.53 | 63,843 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-02-12 | 12,454 | $115.64 | 51,389 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-02-12 | 8,372 | $116.41 | 43,017 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2018-02-12 | 27,000 | $0.00 | 27,000 | $78.53 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2018-02-12 | No | 4 | M | Direct |
Footnotes
- Includes 148 shares acquired under the Zimmer Biomet Holdings, Inc. (the "Company") Employee Stock Purchase Plan between June 30, 2017 and January 30, 2018 and 198 shares purchased between July 28, 2017 and January 29, 2018 under the dividend reinvestment plan for the Company's common stock.
- Represents the sale of 12,454 shares in multiple transactions, ranging in price from $115.05 to $116.04 per share, resulting in a weighted average sale price of $115.6365. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- Represents the sale of 8,372 shares in multiple transactions, ranging in price from $116.05 to $116.78 per share, resulting in a weighted average sale price of $116.4139. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range.
- Vested annually over four years in increments of 25% each year, commencing on February 12, 2009.
Billionaire Hedge Funds
